Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Arqule, Inc. (NQ: ARQL)
2.770 USD  -0.010 (-0.36%)
Streaming Delayed Price  /  Updated: 9:35 AM EDT, May 21, 2013  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,370
Open 2.780
Bid (Size) 2.770 (900)
Ask (Size) 2.780 (4200)
Prev. Close 2.780
Today's Range 2.760 - 2.780
52wk Range 1.980 - 6.980
Shares Outstanding 62,624,032
Dividend Yield N/A
Top News
More News
Free Research Reports on ARQL, FIO, SODA and WFM Issued by the Bedford Report
May 09, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Arqule, Inc. (ARQL) Posts Q1 Loss of 9c/Share
May 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8315641 for the full story. Read More
from StreetInsider.com News Articles

More News
Read More
ArQule Reports First Quarter 2013 Financial Results
May 08, 2013
from Business Wire News Releases
Trading Radar for 05/08: Wendy's (WEN), Groupon (GRPN), Tesla (TSLA), Activision (ATVI), SodaStream (SODA) Report
May 07, 2013
from StreetInsider.com News Articles
First Manhattan Files Preliminary Proxy Materials with SEC for the Election of Six Directors to Vivus’ Board at the 2013 Annual Meeting
May 01, 2013
from Business Wire News Releases
First Manhattan Comments on Addition to Vivus’ Board of Directors
May 01, 2013
from Business Wire News Releases
ArQule to Report First Quarter 2013 Financial Results on May 8, 2013
May 01, 2013
from Business Wire News Releases
ArQule, Inc. to Present at Needham 12th Annual Healthcare Conference
April 23, 2013
from Business Wire News Releases
Early-Stage Clinical Data Highlights from AACR 2013
April 16, 2013
category DMPI , ARQL , TKMR , and 2 more.
from Bio-Wire.Com
ArQule’s Novel AKT Pathway Inhibitor, ARQ 092, Demonstrates Safety, Target Inhibition in Phase 1 Trial
April 09, 2013
from Business Wire News Releases
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here